Study S000104

Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injections Versus Glucagon Like Peptide 1 Receptor Agonist in Weight Loss

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

Included trial: extracted data ClinicalTrials.gov record

Registration

Registration: NCT05268627
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: SINGLE
Status: UNKNOWN
Enrollment: 38
Start: 2022-01-27
Primary completion: 2023-01-27
Lead sponsor: Mansoura University
Conditions: Obesity
Interventions: DRUG:Liraglutide
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

weight loss [1 year]
Body mass index [1 year]
waist circumference [1 year]
hip circumference [1 year]

Linked records (2)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0049231	Effect of endoscopic ultrasound guided gastric botulinum toxin injections and glucagon like peptide 1 receptor agonist on weight loss Asmaa Gameel, The Egyptian Journal of Internal Medicine	2025	Other trial	DOI	cites ClinicalTrials.gov:NCT05268627
R0006920	Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injections versus Glucagon like peptide 1 Receptor Agonist in weight loss. A Prospective randomized study Gameel A, Research Square	2023	Randomized trial	DOI	cites ClinicalTrials.gov:NCT05268627